Literature DB >> 21800055

Cyclooxygenase-2 -765 G/C polymorphisms and susceptibility to hepatitis B-related liver cancer in Han Chinese population.

Jianhong He1, Quanbao Zhang, Zhijian Ren, Yumin Li, Xun Li, Wence Zhou, Hui Zhang, Wenbo Meng, Jun Yan, Wenting He.   

Abstract

To investigate the relationship of cyclooxygenase-2 (COX-2) polymorphisms [COX-2 -765 G/C (rs 20417)] and susceptibility to hepatitis B-related liver cancer in Han Chinese population. The polymorphisms of COX-2 -765 G/C was detected by polymerase chain reaction based restriction fragment length polymorphism (PCR-RFLP) in 300 patients with hepatitis B, 300 patients with cirrhosis, 300 patients with primary liver carcinoma and 300 health controls. The COX-2 -765 G/C genotypes were GG, GC and CC. There frequencies in the hepatitis B patients were 80.33, 17.67 and 2.00%; in the cirrhosis patients were 77.67, 18.00 and 4.33%; in the patients with primary liver carcinoma were 65.67, 28.33 and 6.00% and in the heathy controls were 87.00, 12.33 and 0.67%, respectively, COX-2 -765 C allele carriers had an increased risk of hepatitis B-related liver cancer. COX-2 -765 C allele carriers having drinking history or family history of liver cancer had higher risk for HCC. COX-2 -765 C allele genotype, drinking history and family history of liver cancer may increase the susceptibility to hepatitis B-related liver cancer in Gansu province, China.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800055     DOI: 10.1007/s11033-011-1199-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  [A study on the genetic epidemiology of hepatocellular carcinoma].

Authors:  Wei Meng; Hongyan Lu; Rulin Cai; Feng Jiang; Qingwu Jiang; Wenyao Lin; Fumin Shen
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2002-12

2.  Cyclooxygenase-2 expression in hepatocellular carcinoma.

Authors:  G Shiota; M Okubo; T Noumi; N Noguchi; K Oyama; Y Takano; K Yashima; Y Kishimoto; H Kawasaki
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

3.  COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk.

Authors:  Juliët H Hoff; Rene H M te Morsche; Hennie M J Roelofs; Elise M J van der Logt; Fokko M Nagengast; Wilbert H M Peters
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

4.  The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression.

Authors:  Enrique Lara-Pezzi; Maria Victoria Gómez-Gaviro; Beatriz G Gálvez; Emilia Mira; Miguel A Iñiguez; Manuel Fresno; Carlos Martínez-A; Alicia G Arroyo; Manuel López-Cabrera
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 5.  Effects of hepatitis B virus X protein on the development of liver cancer.

Authors:  Xiaodong Zhang; Hang Zhang; Lihong Ye
Journal:  J Lab Clin Med       Date:  2006-02

6.  Polymorphisms cyclooxygenase-2 -765G>C and interleukin-6 -174G>C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts.

Authors:  Dolores Corella; José Ignacio González; Mònica Bulló; Paula Carrasco; Olga Portolés; Javier Díez-Espino; María Isabel Covas; Valentina Ruíz-Gutierrez; Enrique Gómez-Gracia; Fernando Arós; Miquel Fiol; Manuel Conde Herrera; José Manuel Santos; Guillermo Sáez; Rosa Lamuela; Carlos Lahoz; Ernest Vinyoles; Emilio Ros; Ramón Estruch
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

7.  MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.

Authors:  Antonio Strillacci; Cristiana Griffoni; Pasquale Sansone; Paola Paterini; Giulia Piazzi; Giorgia Lazzarini; Enzo Spisni; Maria Abbondanza Pantaleo; Guido Biasco; Vittorio Tomasi
Journal:  Exp Cell Res       Date:  2008-12-24       Impact factor: 3.905

8.  The COX-2 promoter polymorphism -765 G>C is associated with early-onset, conventional and stump gastric cancers.

Authors:  Robert Sitarz; Roos J Leguit; Wendy W J de Leng; Mirjam Polak; Folkert M Morsink; Onno Bakker; Ryszard Maciejewski; G Johan A Offerhaus; Anya N Milne
Journal:  Mod Pathol       Date:  2008-02-29       Impact factor: 7.842

9.  Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study .

Authors:  Lydia Giannitrapani; Sabrina Ingrao; Maurizio Soresi; Ada Maria Florena; Emanuele La Spada; Luigi Sandonato; Natale D'Alessandro; Melchiorre Cervello; Giuseppe Montalto
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

10.  Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.

Authors:  M E Mendy; T Welzel; O A Lesi; P Hainaut; A J Hall; M H Kuniholm; S McConkey; J J Goedert; S Kaye; S Rowland-Jones; H Whittle; G D Kirk
Journal:  J Viral Hepat       Date:  2009-10-27       Impact factor: 3.728

View more
  10 in total

1.  Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer's disease risk in Chinese.

Authors:  Wenlu Tang; Meixia He; Bo Yang; Kankan Wei; Ming Yin; Lirong Zhang
Journal:  Neurol Sci       Date:  2012-05-24       Impact factor: 3.307

Review 2.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

Review 3.  Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.

Authors:  Hexing Wu; Xiangwei Wu; Guoxing Wan; Shijie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  The association between cyclooxygenase-2 1195 G/A polymorphism and hepatocellular carcinoma: evidence from a meta-analysis.

Authors:  Xianmin Bu; Chenghai Zhao
Journal:  Tumour Biol       Date:  2013-03-14

5.  Prospective cohort studies of association between family history of liver cancer and risk of liver cancer.

Authors:  Yang Yang; Qi-Jun Wu; Li Xie; Wong-Ho Chow; Nat Rothman; Hong-Lan Li; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2014-03-07       Impact factor: 7.396

Review 6.  Influence of four polymorphisms in ABCA1 and PTGS2 genes on risk of Alzheimer's disease: a meta-analysis.

Authors:  Qicong Chen; Biyu Liang; Ziyou Wang; Xiaoguang Cheng; Yifeng Huang; Yong Liu; Zunnan Huang
Journal:  Neurol Sci       Date:  2016-05-23       Impact factor: 3.307

7.  Prostaglandin Endoperoxide H Synthase-2 (PGHS-2) Variants and Risk of Obesity and Microvascular Dysfunction Among Tunisians: Relevance of rs5277 (306G/C) and rs5275 (8473T/C) Genetic Markers.

Authors:  Ahlem Touir; Soumaya Boumiza; Hela Ben Nasr; Sarra Bchir; Zouhair Tabka; Xavier Norel; Karim Chahed
Journal:  Biochem Genet       Date:  2021-04-30       Impact factor: 1.890

8.  COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis.

Authors:  Xiao-feng Wang; Ming-zhu Huang; Xiao-wei Zhang; Rui-xi Hua; Wei-jian Guo
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

9.  The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.

Authors:  Zhigang Chen; Jiye Zhu; Chaoyuan Huang; Fang Lian; Guobin Wu; Yinnong Zhao
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

Review 10.  Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis.

Authors:  Si-Cong Lu; Jian-Hong Zhong; Jun-Tao Tan; Hua-Lin Tang; Xiao-Guang Liu; Bang-De Xiang; Le-Qun Li; Tao Peng
Journal:  BMJ Open       Date:  2015-10-05       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.